Defining Proficiency for The Society of Thoracic Surgeons Participants Performing Thoracoscopic Lobectomy.


Journal

The Annals of thoracic surgery
ISSN: 1552-6259
Titre abrégé: Ann Thorac Surg
Pays: Netherlands
ID NLM: 15030100R

Informations de publication

Date de publication:
01 2019
Historique:
received: 29 01 2018
revised: 13 07 2018
accepted: 17 07 2018
pubmed: 3 10 2018
medline: 16 10 2019
entrez: 2 10 2018
Statut: ppublish

Résumé

Parameters defining attainment and maintenance of proficiency in thoracoscopic video-assisted thoracic surgery (VATS) lobectomy remain unknown. To address this knowledge gap, this study investigated the institutional performance curve for VATS lobectomy by using risk-adjusted cumulative sum (Cusum) analysis. Using The Society of Thoracic Surgeons General Thoracic Surgery Database, the study investigators identified centers that had performed a total of 30 or more VATS lobectomies. Major morbidity, mortality, and blood transfusion were deemed primary outcomes, with expected incidence derived from risk-adjusted regression models. Acceptable and unacceptable failure rates for outcomes were set a priori according to clinical relevance and informed by regression model output. Between 2001 and 2016, 24,196 patients underwent VATS lobectomy at 159 centers with a median volume of 103 (range, 30 to 760). Overall rates of operative mortality, major morbidity, and transfusion were 1% (244 of 24,189), 17.1% (4,145 of 24,196), and 4% (975 of 24,196), respectively. Of the highest-volume centers (≥100 cases), 84% (65 of 77) and 82 % (63 of 77) (p = 0.48) were proficient by major morbidity standards by their 50th and 100th cases, respectively. Similarly, 92% (71 of 77) and 90% (69 of 77) (p = 0.41) of centers showed proficiency by transfusion standards by their 50th and 100th cases, respectively. Three performance patterns were observed: (1) initial and sustained proficiency, (2) crossing unacceptability thresholds with subsequent improved performance; and (3) crossing unacceptability thresholds without subsequent improved performance. VATS lobectomy outcomes have improved with lower mortality and transfusion rates. The majority of high-volume centers demonstrated proficiency after 50 cases; however, maintenance of proficiency is not ensured. Cusum provides a simple yet powerful tool that can trigger internal audits and performance improvement initiatives.

Sections du résumé

BACKGROUND
Parameters defining attainment and maintenance of proficiency in thoracoscopic video-assisted thoracic surgery (VATS) lobectomy remain unknown. To address this knowledge gap, this study investigated the institutional performance curve for VATS lobectomy by using risk-adjusted cumulative sum (Cusum) analysis.
METHODS
Using The Society of Thoracic Surgeons General Thoracic Surgery Database, the study investigators identified centers that had performed a total of 30 or more VATS lobectomies. Major morbidity, mortality, and blood transfusion were deemed primary outcomes, with expected incidence derived from risk-adjusted regression models. Acceptable and unacceptable failure rates for outcomes were set a priori according to clinical relevance and informed by regression model output.
RESULTS
Between 2001 and 2016, 24,196 patients underwent VATS lobectomy at 159 centers with a median volume of 103 (range, 30 to 760). Overall rates of operative mortality, major morbidity, and transfusion were 1% (244 of 24,189), 17.1% (4,145 of 24,196), and 4% (975 of 24,196), respectively. Of the highest-volume centers (≥100 cases), 84% (65 of 77) and 82 % (63 of 77) (p = 0.48) were proficient by major morbidity standards by their 50th and 100th cases, respectively. Similarly, 92% (71 of 77) and 90% (69 of 77) (p = 0.41) of centers showed proficiency by transfusion standards by their 50th and 100th cases, respectively. Three performance patterns were observed: (1) initial and sustained proficiency, (2) crossing unacceptability thresholds with subsequent improved performance; and (3) crossing unacceptability thresholds without subsequent improved performance.
CONCLUSIONS
VATS lobectomy outcomes have improved with lower mortality and transfusion rates. The majority of high-volume centers demonstrated proficiency after 50 cases; however, maintenance of proficiency is not ensured. Cusum provides a simple yet powerful tool that can trigger internal audits and performance improvement initiatives.

Identifiants

pubmed: 30273574
pii: S0003-4975(18)31328-6
doi: 10.1016/j.athoracsur.2018.07.074
pii:
doi:

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

202-208

Subventions

Organisme : NCI NIH HHS
ID : K07 CA178120
Pays : United States

Informations de copyright

Copyright © 2019 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Auteurs

Varun Puri (V)

Department of Surgery, Washington University School of Medicine, St. Louis, Missouri. Electronic address: varunpuri@wustl.edu.

Henning A Gaissert (HA)

Division of Thoracic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

David W Wormuth (DW)

Department of Surgery, St. Joseph's Hospital, Syracuse, New York.

Eric L Grogan (EL)

Department of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.

William R Burfeind (WR)

Department of Surgery, St. Luke's University Hospital, Bethlehem, Pennsylvania.

Andrew C Chang (AC)

Department of Surgery, University of Michigan, Ann Arbor, Michigan.

Christopher W Seder (CW)

Department of Cardiovascular and Thoracic Surgery, Rush University Medical Center, Chicago, Illinois.

Felix G Fernandez (FG)

Emory University School of Medicine, Atlanta, Georgia.

Lisa Brown (L)

Department of Surgery, University of California Davis Health, Sacramento, California.

Mitchell J Magee (MJ)

Department of Surgery, Baylor University Medical Center, Dallas, Texas.

Andrzej S Kosinski (AS)

Department of Biostatistics and Bioinformatics and Duke Clinical Research Institute, Duke University, Durham, North Carolina.

Daniel P Raymond (DP)

Thoracic and Cardiovascular Surgery, Cleveland Clinic Foundation, Cleveland, Ohio.

Stephen R Broderick (SR)

Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Robert J Welsh (RJ)

Department of Surgery, Beaumont Health, Royal Oak, Michigan.

Malcolm M DeCamp (MM)

Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.

Farhood Farjah (F)

Department of Surgery, University of Washington, Seattle, Washington.

Melanie A Edwards (MA)

Division of Cardiothoracic Surgery, Saint Louis University School of Medicine, St. Louis, Missouri.

Benjamin D Kozower (BD)

Department of Surgery, Washington University School of Medicine, St. Louis, Missouri.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH